Samuel Eaton, MD
Urology · Newport, RINPI 1407026479
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,750 of the $10,401 with a category attached, or 64.9%. Boston Scientific accounts for 81.0% of it on its own, with 9 other manufacturers making up the rest.
Across 37 payments — averaging $281.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Procept Biorobotics Corporation$866
- Teleflex LLC$369
- Ambu Inc.$152
- SRS Medical Systems, Inc.$146
- Olympus America Inc.$132
- plus $307 from 4 others
What the payments were for
- Consulting fees$6,75065%
- Travel & lodging$2,12620%
- Food & beverage$1,37913%
- Education$1461%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $8,428 |
| Procept Biorobotics Corporation | 2 | $866 |
| Teleflex LLC | 6 | $369 |
| Ambu Inc. | 1 | $152 |
| SRS Medical Systems, Inc. | 1 | $146 |
| Olympus America Inc. | 2 | $132 |
| Coloplast | 1 | $111 |
| Intuitive Surgical | 2 | $101 |
| Olympus Corporation Of The Americas | 1 | $61 |
| AstraZeneca | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$2,925
- AquaBeam Robotic System$837
- CT3000 Pro Base Unit$146
- UroCuff-DC Disposable, Single$146
- UroLift System$146
- UroLift$127
- RETRACE$111
How this compares
$10,401 in reported general payments places this provider in the 80th percentile of 55 urology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $18,130 |
| GemtesaVibegron | 22 | $12,279 |
| Potassium Citrate ErPotassium Citrate | 32 | $3,686 |
| Tamsulosin Hcl | 234 | $3,559 |
| Trospium Chloride | 25 | $1,405 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 43 | $988 |
| Silodosin | 12 | $651 |
| Finasteride | 46 | $430 |
| CefuroximeCefuroxime Axetil | 34 | $392 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 40 | $372 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 50 | $217 |
| Chlorthalidone | 11 | $156 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $133 |
| Cephalexin | 15 | $74 |
| Ciprofloxacin Hcl | 16 | $68 |
Paid to pharmacies, not to this prescriber.
Other urology in Newport
- John HeffernanNewport$9K
- Joseph HeinemanNewport$5K
- Arnold SarazenNewport$3K
- Richard ZuernerNewport$27
- Dicken KoProvidence$158K
- Gyan PareekProvidence$83K
- Joseph RenzulliProvidence$81K
- Simone ThavaseelanProvidence$16K
- Boris GershmanProvidence$13K
- Mark LeoWest Warwick$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.